Shuchen Chen Selected Research

Shuchen Chen Research Topics

Disease

12	Neoplasms (Cancer) 08/2023 - 01/2013
5	Esophageal Squamous Cell Carcinoma 08/2023 - 12/2017
4	Carcinogenesis 05/2024 - 01/2019
4	Esophageal Neoplasms (Esophageal Cancer) 01/2022 - 09/2014
3	Colorectal Neoplasms (Colorectal Cancer) 09/2017 - 01/2015
2	Adenocarcinoma of Lung 01/2024 - 05/2021
2	Neoplasm Metastasis (Metastasis) 05/2023 - 01/2023
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 01/2016
2	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 01/2015 - 01/2015
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024
1	Anastomotic Leak 08/2023
1	Lymphatic Metastasis 05/2023
1	Lung Neoplasms (Lung Cancer) 01/2023
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2022
1	Cholangiocarcinoma 11/2022
1	Atrial Fibrillation 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Hemorrhage 01/2022
1	Nervous System Diseases (Neurological Disorders) 10/2021
1	Lung Diseases (Lung Disease) 08/2020
1	Ascites 05/2020
1	Heart Failure 05/2020
1	Accidental Injuries 05/2020
1	Chylothorax 05/2020
1	Pleural Effusion (Pleural Effusions) 05/2020
1	Adenocarcinoma 12/2017
1	Leiomyoma (Uterine Fibroids) 11/2017
1	Type 2 Diabetes Mellitus (MODY) 09/2017
1	Fistula 01/2016
1	Melanoma (Melanoma, Malignant) 01/2015
1	Breast Neoplasms (Breast Cancer) 01/2015
1	Mouth Neoplasms (Oral Cancer) 01/2015
1	Pulmonary Edema 11/2012
1	Lung Injury 11/2012
1	Ischemia 11/2012

Drug/Important Bio-Agent (IBA)

3	PPAR gammaIBA 09/2020 - 01/2015
3	ORALIT (ORS)IBA 12/2019 - 01/2015
3	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 12/2017 - 01/2015
2	Vascular Endothelial Growth Factor CIBA 05/2024 - 05/2023
2	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 05/2024 - 05/2023
2	Leptin ReceptorsIBA 04/2024 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 08/2020
2	Protein Isoforms (Isoforms)IBA 01/2022 - 10/2021
2	Interleukin-4 (Interleukin 4)IBA 08/2021 - 01/2020
2	Transcription Factors (Transcription Factor)IBA 12/2017 - 09/2017
1	Long Noncoding RNAIBA 01/2024
1	Immune Checkpoint InhibitorsIBA 08/2023
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 05/2023
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 05/2023
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 11/2022
1	AlbuminsIBA 01/2022
1	Cell-Free Nucleic AcidsIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Hemoglobins (Hemoglobin)IBA 01/2022
1	Peptide Elongation Factor 1 (EF-1)IBA 10/2021
1	Peptide Elongation Factors (Elongation Factor)IBA 10/2021
1	Interleukin-4 Receptors (Interleukin 4 Receptor)IBA 08/2021
1	rho GTPase-activating proteinIBA 05/2021
1	Aryldialkylphosphatase (Paraoxonase)IBA 09/2020
1	Interleukin-10 (Interleukin 10)IBA 01/2020
1	Member 14 Tumor Necrosis Factor ReceptorsIBA 01/2020
1	EndonucleasesIBA 12/2019
1	MicroRNAs (MicroRNA)IBA 01/2019
1	LeptinIBA 12/2017
1	Polypropylenes (Polypropylene)IBA 11/2017
1	Glucose (Dextrose)FDA LinkGeneric 09/2017
1	Diatrizoate Meglumine (Gastrograffin)FDA LinkGeneric 01/2016
1	Cyclin D1IBA 01/2016
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2015
1	Insulin Receptor Substrate ProteinsIBA 01/2015
1	CTLA-4 AntigenIBA 01/2015
1	Peroxidase (Myeloperoxidase)IBA 11/2012
1	Superoxide DismutaseIBA 11/2012
1	Malondialdehyde (Propanedial)IBA 11/2012
1	Oxygen (Dioxygen)IBA 11/2012
1	CytokinesIBA 11/2012

Therapy/Procedure

5	Esophagectomy 08/2023 - 09/2014
3	Therapeutics 08/2023 - 10/2021
2	Immunotherapy 08/2023 - 08/2023
2	Neoadjuvant Therapy 08/2023 - 01/2022
2	Lymph Node Excision (Lymph Node Dissection) 03/2016 - 01/2013
1	Drug Therapy (Chemotherapy) 08/2023
1	Radiotherapy 08/2023
1	Segmental Mastectomy (Lumpectomy) 01/2023
1	Length of Stay 01/2022
1	Operative Time 01/2022
1	Operative Surgical Procedures 05/2020
1	Ischemic Postconditioning 11/2012